CG
Carmignac Gestion’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,176
| Closed | -$512K | – | 137 |
|
2025
Q1 | $512K | Sell |
1,176
-461,600
| -100% | -$201M | 0.01% | 133 |
|
2024
Q4 | $171M | Buy |
462,776
+148,200
| +47% | +$54.7M | 2.72% | 14 |
|
2024
Q3 | $164M | Buy |
314,576
+192,150
| +157% | +$99.9M | 2.73% | 13 |
|
2024
Q2 | $66.3M | Buy |
+122,426
| New | +$66.3M | 1.14% | 23 |
|
2023
Q3 | – | Sell |
-43,665
| Closed | -$19.4M | – | 151 |
|
2023
Q2 | $19.4M | Sell |
43,665
-264,698
| -86% | -$118M | 0.33% | 49 |
|
2023
Q1 | $142M | Sell |
308,363
-141,176
| -31% | -$64.9M | 2.36% | 17 |
|
2022
Q4 | $231M | Sell |
449,539
-29,585
| -6% | -$15.2M | 4.17% | 6 |
|
2022
Q3 | $218M | Sell |
479,124
-26,883
| -5% | -$12.2M | 4.68% | 6 |
|
2022
Q2 | $244M | Sell |
506,007
-100,321
| -17% | -$48.4M | 5.17% | 4 |
|
2022
Q1 | $298M | Sell |
606,328
-129,768
| -18% | -$63.8M | 4.81% | 6 |
|
2021
Q4 | $341M | Sell |
736,096
-55,054
| -7% | -$25.5M | 4.77% | 6 |
|
2021
Q3 | $295M | Sell |
791,150
-2,570
| -0.3% | -$958K | 3.68% | 8 |
|
2021
Q2 | $303M | Sell |
793,720
-126,914
| -14% | -$48.5M | 3.51% | 8 |
|
2021
Q1 | $330M | Buy |
920,634
+1,272
| +0.1% | +$457K | 3.79% | 6 |
|
2020
Q4 | $295M | Buy |
919,362
+107,166
| +13% | +$34.4M | 3.09% | 7 |
|
2020
Q3 | $218M | Sell |
812,196
-2,303
| -0.3% | -$619K | 2.58% | 10 |
|
2020
Q2 | $214M | Buy |
814,499
+32,959
| +4% | +$8.67M | 2.96% | 9 |
|
2020
Q1 | $177M | Sell |
781,540
-226,775
| -22% | -$51.5M | 3.03% | 9 |
|
2019
Q4 | $305M | Sell |
1,008,315
-26,778
| -3% | -$8.09M | 4.07% | 6 |
|
2019
Q3 | $249M | Buy |
1,035,093
+9,814
| +1% | +$2.36M | 3.14% | 7 |
|
2019
Q2 | $289M | Sell |
1,025,279
-149,186
| -13% | -$42.1M | 3.59% | 6 |
|
2019
Q1 | $337M | Buy |
1,174,465
+197,289
| +20% | +$56.6M | 3.93% | 5 |
|
2018
Q4 | $257M | Buy |
977,176
+298,943
| +44% | +$78.5M | 3.88% | 8 |
|
2018
Q3 | $186M | Buy |
+678,233
| New | +$186M | 1.58% | 28 |
|